Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Neoplasms × apatinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 7 OTHER 6 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1 nabiximols 1 apatinib 1 Sunitinib 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03199677 2017-07-02

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

ChineseAMS

Phase 2 Unknown

Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡